Cargando…

18-Fluorodeoxy-Glucose Positron Emission Tomography-Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy

PURPOSE: Evaluation of the 18-fluorodeoxy-glucose positron emission tomography-computed tomography (18-FDG-PET/(CT)) for gross tumor volume (GTV) delineation in gastric cancer patients undergoing radiotherapy. METHODS: In this study, 29 gastric cancer patients (17 unresectable and 7 inoperable) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Dębiec, Kinga, Wydmański, Jerzy, Gorczewska, Izabela, Leszczyńska, Paulina, Gorczewski, Kamil, Leszczyński, Wojciech, d’Amico, Andrea, Kalemba, Michał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773782/
https://www.ncbi.nlm.nih.gov/pubmed/29172270
http://dx.doi.org/10.22034/APJCP.2017.18.11.2989
_version_ 1783293634051833856
author Dębiec, Kinga
Wydmański, Jerzy
Gorczewska, Izabela
Leszczyńska, Paulina
Gorczewski, Kamil
Leszczyński, Wojciech
d’Amico, Andrea
Kalemba, Michał
author_facet Dębiec, Kinga
Wydmański, Jerzy
Gorczewska, Izabela
Leszczyńska, Paulina
Gorczewski, Kamil
Leszczyński, Wojciech
d’Amico, Andrea
Kalemba, Michał
author_sort Dębiec, Kinga
collection PubMed
description PURPOSE: Evaluation of the 18-fluorodeoxy-glucose positron emission tomography-computed tomography (18-FDG-PET/(CT)) for gross tumor volume (GTV) delineation in gastric cancer patients undergoing radiotherapy. METHODS: In this study, 29 gastric cancer patients (17 unresectable and 7 inoperable) were initially enrolled for radical chemoradiotherapy (45Gy/25 fractions + chemotherapy based on 5 fluorouracil) or radiotherapy alone (45Gy/25 fractions) with planning based on the 18-FDG-PET/CT images. Five patients were excluded due to excess blood glucose levels (1), false-negative positron emission tomography (1) and distant metastases revealed by 18-FDG-PET/CT (3). The analysis involved measurement of metabolic tumor volumes (MTVs) performed on PET/CT workstations. Different threshold levels of the standardized uptake value (SUV) and liver uptake were set to obtain MTVs. Secondly, GTV(PET) values were derived manually using the positron emission tomography (PET) dataset blinded to the computed tomography (CT) data. Subsequently, GTV(CT) values were delineated using a radiotherapy planning system based on the CT scans blinded to the PET data. The referenced GTV(CT) values were correlated with the GTV(PET) and were compared with a conformality index (CI). RESULTS: The mean CI was 0.52 (range, 0.12-0.85). In 13/24 patients (54%), the GTV(PET) was larger than GTV(CT), and in the remainder, GTV(PET) was smaller. Moreover, the cranio-caudal diameter of GTV(PET) in 16 cases (64%) was larger than that of GTV(CT), smaller in 7 cases (29%), and unchanged in one case. Manual PET delineation (GTVPET) achieved the best correlation with GTV(CT) (Pearson correlation = 0.76, p <0.0001). Among the analyzed MTVs, a statistically significant correlation with GTV(CT) was revealed for MTV(10%SUVmax) (r = 0.63; p = 0.0014), MTV(liv) (r = 0.60; p = 0.0021), MTV(SUV2.5) (r = 0.54; p = 0.0063); MTV(20%SUVmax) (r = 0.44; p = 0.0344); MTV(30%SUVmax) (r = 0.44; p = 0.0373). CONCLUSION: 18-FDG-PET/(CT) in gastric cancer radiotherapy planning may affect the GTV delineation.
format Online
Article
Text
id pubmed-5773782
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-57737822018-02-01 18-Fluorodeoxy-Glucose Positron Emission Tomography-Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy Dębiec, Kinga Wydmański, Jerzy Gorczewska, Izabela Leszczyńska, Paulina Gorczewski, Kamil Leszczyński, Wojciech d’Amico, Andrea Kalemba, Michał Asian Pac J Cancer Prev Research Article PURPOSE: Evaluation of the 18-fluorodeoxy-glucose positron emission tomography-computed tomography (18-FDG-PET/(CT)) for gross tumor volume (GTV) delineation in gastric cancer patients undergoing radiotherapy. METHODS: In this study, 29 gastric cancer patients (17 unresectable and 7 inoperable) were initially enrolled for radical chemoradiotherapy (45Gy/25 fractions + chemotherapy based on 5 fluorouracil) or radiotherapy alone (45Gy/25 fractions) with planning based on the 18-FDG-PET/CT images. Five patients were excluded due to excess blood glucose levels (1), false-negative positron emission tomography (1) and distant metastases revealed by 18-FDG-PET/CT (3). The analysis involved measurement of metabolic tumor volumes (MTVs) performed on PET/CT workstations. Different threshold levels of the standardized uptake value (SUV) and liver uptake were set to obtain MTVs. Secondly, GTV(PET) values were derived manually using the positron emission tomography (PET) dataset blinded to the computed tomography (CT) data. Subsequently, GTV(CT) values were delineated using a radiotherapy planning system based on the CT scans blinded to the PET data. The referenced GTV(CT) values were correlated with the GTV(PET) and were compared with a conformality index (CI). RESULTS: The mean CI was 0.52 (range, 0.12-0.85). In 13/24 patients (54%), the GTV(PET) was larger than GTV(CT), and in the remainder, GTV(PET) was smaller. Moreover, the cranio-caudal diameter of GTV(PET) in 16 cases (64%) was larger than that of GTV(CT), smaller in 7 cases (29%), and unchanged in one case. Manual PET delineation (GTVPET) achieved the best correlation with GTV(CT) (Pearson correlation = 0.76, p <0.0001). Among the analyzed MTVs, a statistically significant correlation with GTV(CT) was revealed for MTV(10%SUVmax) (r = 0.63; p = 0.0014), MTV(liv) (r = 0.60; p = 0.0021), MTV(SUV2.5) (r = 0.54; p = 0.0063); MTV(20%SUVmax) (r = 0.44; p = 0.0344); MTV(30%SUVmax) (r = 0.44; p = 0.0373). CONCLUSION: 18-FDG-PET/(CT) in gastric cancer radiotherapy planning may affect the GTV delineation. West Asia Organization for Cancer Prevention 2017 /pmc/articles/PMC5773782/ /pubmed/29172270 http://dx.doi.org/10.22034/APJCP.2017.18.11.2989 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Research Article
Dębiec, Kinga
Wydmański, Jerzy
Gorczewska, Izabela
Leszczyńska, Paulina
Gorczewski, Kamil
Leszczyński, Wojciech
d’Amico, Andrea
Kalemba, Michał
18-Fluorodeoxy-Glucose Positron Emission Tomography-Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy
title 18-Fluorodeoxy-Glucose Positron Emission Tomography-Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy
title_full 18-Fluorodeoxy-Glucose Positron Emission Tomography-Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy
title_fullStr 18-Fluorodeoxy-Glucose Positron Emission Tomography-Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy
title_full_unstemmed 18-Fluorodeoxy-Glucose Positron Emission Tomography-Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy
title_short 18-Fluorodeoxy-Glucose Positron Emission Tomography-Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy
title_sort 18-fluorodeoxy-glucose positron emission tomography-computed tomography (18-fdg-pet/ct) for gross tumor volume (gtv) delineation in gastric cancer radiotherapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773782/
https://www.ncbi.nlm.nih.gov/pubmed/29172270
http://dx.doi.org/10.22034/APJCP.2017.18.11.2989
work_keys_str_mv AT debieckinga 18fluorodeoxyglucosepositronemissiontomographycomputedtomography18fdgpetctforgrosstumorvolumegtvdelineationingastriccancerradiotherapy
AT wydmanskijerzy 18fluorodeoxyglucosepositronemissiontomographycomputedtomography18fdgpetctforgrosstumorvolumegtvdelineationingastriccancerradiotherapy
AT gorczewskaizabela 18fluorodeoxyglucosepositronemissiontomographycomputedtomography18fdgpetctforgrosstumorvolumegtvdelineationingastriccancerradiotherapy
AT leszczynskapaulina 18fluorodeoxyglucosepositronemissiontomographycomputedtomography18fdgpetctforgrosstumorvolumegtvdelineationingastriccancerradiotherapy
AT gorczewskikamil 18fluorodeoxyglucosepositronemissiontomographycomputedtomography18fdgpetctforgrosstumorvolumegtvdelineationingastriccancerradiotherapy
AT leszczynskiwojciech 18fluorodeoxyglucosepositronemissiontomographycomputedtomography18fdgpetctforgrosstumorvolumegtvdelineationingastriccancerradiotherapy
AT damicoandrea 18fluorodeoxyglucosepositronemissiontomographycomputedtomography18fdgpetctforgrosstumorvolumegtvdelineationingastriccancerradiotherapy
AT kalembamichał 18fluorodeoxyglucosepositronemissiontomographycomputedtomography18fdgpetctforgrosstumorvolumegtvdelineationingastriccancerradiotherapy